Hunt Anthony insider trades
Hunt Anthony has filed 47 Form 4s with the SEC that we hold, for Repligen Corp (RGEN) (Director), 908 Devices Inc. (MASS) (Director) and Biolife Solutions INC (BLFS) (Director). Across all of them we count 1 purchase worth $248.2K and 69 sales worth $59.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 12 sales ($7.0M). The largest single trade was a sale of 25,000 shares of Repligen Corp worth $5.0M, dated 2022-11-11. The first filing on our record is dated 2021-08-18 and the latest 2026-10-08.
Repligen Corp (RGEN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-09 | S, sale reported on Form 4 | 8,536 | $2.5M | 2021-09-13 |
| 2021-09-09 | S, sale reported on Form 4 | 14,825 | $4.4M | 2021-09-13 |
| 2021-09-09 | S, sale reported on Form 4 | 1,631 | $482.9K | 2021-09-13 |
| 2021-09-09 | S, sale reported on Form 4 | 8 | $2.4K | 2021-09-13 |
| 2021-11-18 | S, sale reported on Form 4 | 1,955 | $537.3K | 2021-11-19 |
| 2021-11-18 | S, sale reported on Form 4 | 2,061 | $564.5K | 2021-11-19 |
| 2021-11-18 | S, sale reported on Form 4 | 4,017 | $1.1M | 2021-11-19 |
| 2021-11-18 | S, sale reported on Form 4 | 596 | $167.7K | 2021-11-19 |
| 2021-11-18 | S, sale reported on Form 4 | 970 | $270.7K | 2021-11-19 |
| 2021-11-18 | S, sale reported on Form 4 | 1,732 | $479.8K | 2021-11-19 |
| 2021-11-18 | S, sale reported on Form 4 | 6,024 | $1.7M | 2021-11-19 |
| 2022-07-21 | S, sale reported on Form 4 | 24,802 | $5.0M | 2022-07-22 |
| 2022-09-08 | S, sale reported on Form 4 | 4,873 | $1.1M | 2022-09-09 |
| 2022-09-08 | S, sale reported on Form 4 | 245 | $55.6K | 2022-09-09 |
| 2022-09-08 | S, sale reported on Form 4 | 10,490 | $2.4M | 2022-09-09 |
| 2022-09-08 | S, sale reported on Form 4 | 6,626 | $1.5M | 2022-09-09 |
| 2022-09-08 | S, sale reported on Form 4 | 1,389 | $310.1K | 2022-09-09 |
| 2022-09-08 | S, sale reported on Form 4 | 720 | $160.0K | 2022-09-09 |
| 2022-09-08 | S, sale reported on Form 4 | 1,235 | $273.5K | 2022-09-09 |
| 2022-09-08 | S, sale reported on Form 4 | 824 | $181.3K | 2022-09-09 |
| 2022-11-11 | S, sale reported on Form 4 | 25,000 | $5.0M | 2022-11-14 |
| 2024-03-08 | S, sale reported on Form 4 | 806 | $162.6K | 2024-03-11 |
| 2024-03-08 | S, sale reported on Form 4 | 156 | $31.6K | 2024-03-11 |
| 2024-03-08 | S, sale reported on Form 4 | 1,305 | $261.7K | 2024-03-11 |
| 2024-03-08 | S, sale reported on Form 4 | 1,666 | $328.9K | 2024-03-11 |
| 2024-03-08 | S, sale reported on Form 4 | 1,347 | $267.4K | 2024-03-11 |
| 2024-03-08 | S, sale reported on Form 4 | 1,822 | $363.5K | 2024-03-11 |
| 2024-03-08 | S, sale reported on Form 4 | 3,377 | $660.2K | 2024-03-11 |
| 2024-03-08 | S, sale reported on Form 4 | 6,228 | $1.2M | 2024-03-11 |
| 2024-05-21 | S, sale reported on Form 4 | 3,933 | $662.0K | 2024-05-22 |
| 2024-05-21 | S, sale reported on Form 4 | 3,925 | $667.4K | 2024-05-22 |
| 2024-05-21 | S, sale reported on Form 4 | 969 | $165.7K | 2024-05-22 |
| 2024-05-21 | S, sale reported on Form 4 | 4,008 | $669.5K | 2024-05-22 |
| 2024-05-21 | S, sale reported on Form 4 | 4,274 | $711.0K | 2024-05-22 |
| 2024-05-21 | S, sale reported on Form 4 | 2,963 | $501.5K | 2024-05-22 |
| 2024-06-14 | P, purchase reported on Form 4 | 2,000 | $248.2K | 2024-06-14 |
| 2024-09-10 | S, sale reported on Form 4 | 10,723 | $1.6M | 2024-09-12 |
| 2024-09-10 | S, sale reported on Form 4 | 604 | $88.6K | 2024-09-12 |
| 2024-09-10 | S, sale reported on Form 4 | 9,369 | $1.4M | 2024-09-12 |
| 2024-09-10 | S, sale reported on Form 4 | 1,495 | $214.9K | 2024-09-12 |
| 2024-11-21 | S, sale reported on Form 4 | 24,246 | $3.4M | 2024-11-22 |
| 2025-03-17 | S, sale reported on Form 4 | 2,283 | $350.9K | 2025-03-19 |
| 2025-03-17 | S, sale reported on Form 4 | 15,619 | $2.4M | 2025-03-19 |
| 2025-03-17 | S, sale reported on Form 4 | 6,176 | $938.5K | 2025-03-19 |
| 2025-03-17 | S, sale reported on Form 4 | 2,518 | $380.4K | 2025-03-19 |
| 2025-03-17 | S, sale reported on Form 4 | 100 | $15.0K | 2025-03-19 |
| 2025-03-17 | S, sale reported on Form 4 | 60 | $8.9K | 2025-03-19 |
| 2025-05-15 | S, sale reported on Form 4 | 2,043 | $250.6K | 2025-05-16 |
| 2025-05-15 | S, sale reported on Form 4 | 17,596 | $2.2M | 2025-05-16 |
| 2025-05-15 | S, sale reported on Form 4 | 7 | $889 | 2025-05-16 |
| 2025-05-15 | S, sale reported on Form 4 | 268 | $33.6K | 2025-05-16 |
| 2025-05-15 | S, sale reported on Form 4 | 6,533 | $812.3K | 2025-05-16 |
| 2025-09-10 | S, sale reported on Form 4 | 14,882 | $1.8M | 2025-09-11 |
| 2025-09-10 | S, sale reported on Form 4 | 1,108 | $131.1K | 2025-09-11 |
| 2025-09-10 | S, sale reported on Form 4 | 96 | $11.2K | 2025-09-11 |
| 2025-09-10 | S, sale reported on Form 4 | 2,179 | $266.3K | 2025-09-11 |
| 2025-09-10 | S, sale reported on Form 4 | 3,262 | $390.3K | 2025-09-11 |
| 2025-09-10 | S, sale reported on Form 4 | 7,584 | $920.8K | 2025-09-11 |
| 2025-11-12 | S, sale reported on Form 4 | 3,741 | $579.6K | 2025-11-13 |
| 2025-11-12 | S, sale reported on Form 4 | 4,740 | $738.7K | 2025-11-13 |
| 2025-11-12 | S, sale reported on Form 4 | 4,959 | $776.8K | 2025-11-13 |
| 2025-11-12 | S, sale reported on Form 4 | 464 | $73.5K | 2025-11-13 |
| 2025-11-12 | S, sale reported on Form 4 | 11,096 | $1.8M | 2025-11-13 |
| 2025-11-13 | S, sale reported on Form 4 | 1,784 | $269.4K | 2025-11-14 |
| 2025-11-13 | S, sale reported on Form 4 | 2,100 | $319.6K | 2025-11-14 |
| 2025-11-13 | S, sale reported on Form 4 | 2,923 | $447.6K | 2025-11-14 |
| 2025-11-13 | S, sale reported on Form 4 | 2,500 | $385.8K | 2025-11-14 |
| 2025-11-13 | S, sale reported on Form 4 | 3,000 | $466.3K | 2025-11-14 |
| 2025-11-13 | S, sale reported on Form 4 | 5,737 | $896.2K | 2025-11-14 |
| 2025-11-13 | S, sale reported on Form 4 | 1,956 | $307.3K | 2025-11-14 |
908 Devices Inc. (MASS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Biolife Solutions INC (BLFS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1606030) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms